Tango Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell TNGX and other ETFs, options, and stocks.About TNGX
Tango Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in discovering and delivering precision cancer medicines. It also identifies novel targets and develops new drugs directed at tumor suppressor gene loss in defined patient populations with high unmet medical need.
CEOBarbara L. Weber
CEOBarbara L. Weber
Employees155
Employees155
HeadquartersBoston, Massachusetts
HeadquartersBoston, Massachusetts
Founded2017
Founded2017
Employees155
Employees155
TNGX Key Statistics
Market cap1.26B
Market cap1.26B
Price-Earnings ratio-10.20
Price-Earnings ratio-10.20
Dividend yield—
Dividend yield—
Average volume1.99M
Average volume1.99M
High today—
High today—
Low today—
Low today—
Open price$9.10
Open price$9.10
Volume0.00
Volume0.00
52 Week high$11.20
52 Week high$11.20
52 Week low$1.03
52 Week low$1.03
Stock Snapshot
Tango Therapeutics(TNGX) stock is priced at $9.35, giving the company a market capitalization of 1.26B. It carries a P/E multiple of -10.20.
Tango Therapeutics(TNGX) stock opened on 2025-12-15 at $9.10. The price climbed to — and dipped to —.
Tango Therapeutics(TNGX) shares are trading with a volume of 0, against a daily average of 1.99M.
During the past year, Tango Therapeutics(TNGX) stock moved between $1.03 at its lowest and $11.20 at its peak.
During the past year, Tango Therapeutics(TNGX) stock moved between $1.03 at its lowest and $11.20 at its peak.
Analyst ratings
90%
of 10 ratingsBuy
90%
Hold
10%
Sell
0%
People also own
Based on the portfolios of people who own TNGX. This list is generated using Robinhood data, and it’s not a recommendation.